Form 4: Mind Medicine (MindMed) Director Reports Stock Transaction
Insider Transaction (Form 4)
Andreas Krebs, a Director of Mind Medicine (MindMed) Inc., reported multiple transactions in common stock on September 18, 2026.
Summary
- Option exercise/conversion: acquired 1,629 Common Shares at $35.52 ($57,862) on September 18, 2026; holds 21,402 after (Direct).
- Option exercise/conversion: disposed of 1,629 Stock Option (Right to Buy) on September 18, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andreas Krebs — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-18 | Option exercise/conversion | Common Shares | 1,629 | $36 | $57.9K | 21,402 |
| 2026-09-18 | Option exercise/conversion | Stock Option (Right to Buy) | 1,629 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-18 | Option exercise/conversion (1,629 shares) |
| 2026-09-18 | Option exercise/conversion (1,629 shares) |
Keywords
insider transaction, Form 4, DFTX, Definium Therapeutics, Inc., neutral, Andreas Krebs
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.